A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is
Masterful Antibodies: Checkpoint Blockade
Cancer immunology research
Cancer therapeutics that target the immune system rather than the cancer cell itself are becoming standard of care in a growing number of different malignancies. Although cancer immunotherapy is not a new concept, the potential importance of this class of drugs was probably not fully appreciated as recently as a decade ago when much of the focus of cancer drug discovery was on cancer cell-targeted medicines. The authors were lucky enough to be able to witness and participate in the discoverydoi:10.1158/2326-6066.cir-17-0057 pmid:28373215 fatcat:wequmf6ncvgbhcqtpsnjcug3ce